✦ LIBER ✦

MC1 COMPARISON OF REFILL GAP ANALYSIS METHODOLOGIES IN A POPULATION OF PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING ADALIMUMAB OR ETANERCEPT

✍ Scribed by C. Carter; S. Bolge; M. Ingham; C. Schmeichel-Mueller

Book ID: 119308791
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 58 KB
Volume: 14
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2011.02.050

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term anti-TNF therapy and the risk

Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: Comparison of adalimumab, etanercept and infliximab in the GISEA registry

✍ Atzeni, Fabiola; Sarzi-Puttini, Piercarlo; Botsios, Costantino; Carletto, Antoni 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 180 KB

Use of tumor necrosis factor-α (TNF-α) a

Use of tumor necrosis factor-α (TNF-α) antagonists infliximab, etanercept, and adalimumab in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective record review of 11 patients

✍ Sophia Li; Primal P. Kaur; Virginia Chan; Steven Berney 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 102 KB

Direct comparison of treatment responses

Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: Results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry

✍ Merete Lund Hetland; Ib Jarle Christensen; Ulrik Tarp; Lene Dreyer; Annette Hans 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views